The KPNA4 Knockout HAP1 Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal knockout cell population targeting the human KPNA4 gene in HAP1 cells. This model ablates karyopherin alpha 4, an importin alpha family adaptor essential for classical nuclear localization signal (NLS)-mediated protein import. The polyclonal format provides a heterogeneous pool of edited cells, facilitating robust loss-of-function studies without clonal bias. It serves as a versatile tool for dissecting nucleocytoplasmic transport mechanisms and downstream cellular phenotypes in a genetically tractable human system.
HAP1 cells are a near-haploid human cell line derived from the chronic myeloid leukemia line KBM-7. Their haploid genome simplifies genetic analysis by eliminating heterozygous complexity, enabling clear genotype-phenotype relationships. This characteristic is particularly valuable for knockout studies of nuclear transport factors like KPNA4, where functional redundancy with other importin alpha isoforms could mask phenotypes in diploid cells. HAP1 cells exhibit stable growth and are amenable to standard cell biology and biochemical assays.
KPNA4 functions as an adaptor that recognizes classical NLS motifs on cargo proteins and links them to importin beta (KPNB1) for nuclear pore passage. It mediates nuclear import of transcription factors such as NF-??B, p53, and STAT1, as well as viral proteins including influenza virus NP and HIV-1 integrase. The ternary cargo-KPNA4-KPNB1 complex docks with nucleoporins NUP98 and NUP153, and translocation is driven by RanGTP, which dissociates the complex inside the nucleus. Upstream regulators include cell cycle progression and mitogenic signals, while downstream targets regulate proliferation, apoptosis, and antiviral responses. Representative pathway members include KPNA4, KPNB1, RAN, RANBP2, NUP98, and NUP153.
In the HAP1 context, KPNA4 disruption impairs nuclear import of multiple NLS cargoes, permitting dissection of transport-dependent signaling pathways. This is directly relevant to cancer research, as KPNA4-mediated import of NF-??B and p53 is linked to hepatocellular carcinoma and breast cancer pathogenesis. The model also facilitates antiviral studies by eliminating host factor support for influenza and HIV nuclear entry. Additionally, the chronic myeloid leukemia background enables investigation of nucleocytoplasmic trafficking in hematopoietic malignancies.
Applications include nuclear import assays with fluorescent NLS reporters, immunofluorescence localization of cargo proteins, and co-immunoprecipitation to probe KPNA4 interactions. Transcriptomic analysis via RNA-seq and cell proliferation assays reveal functional consequences of KPNA4 loss. Western blotting and RT-qPCR confirm target disruption. The polyclonal cells are suitable for drug target discovery in cancer and viral diseases. For additional details, please contact Ascent Research.
